Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys
- PMID: 18644417
- DOI: 10.1016/j.vaccine.2008.07.005
Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys
Abstract
We undertook a study to demonstrate the potential contribution of oral-fluid (OF) antibody prevalence surveys in evaluating measles vaccine campaigns. In Asela town, southern Ethiopia, oral fluids were collected from 1928 children aged 9 months to 5 years attending for campaign immunization in December 1999 and 6 months later, from 745 individuals aged 9 months to 19 years, in the same location. Measles antibody status was determined by microimmune measles specific IgG enzyme immunoassay (EIA). Antibody prevalence was estimated at 48% in children attending for vaccination (pre-campaign), and 85% post-campaign in the comparable age group. The estimated reduction in the susceptible proportion was 75%. In older children the proportion antibody negative post-campaign was 28% in 7-9 year olds, and 13% in 10-14 year olds levels of susceptibility which raise concern over continued measles transmission. This is the first evaluation of a measles vaccine campaign based on oral-fluid seroprevalence surveys and it demonstrates the merit of oral-fluid surveys in informing health authorities about vaccination strategy refinement.
Similar articles
-
Seroepidemiology of measles in Addis Ababa, Ethiopia: implications for control through vaccination.Epidemiol Infect. 2003 Jun;130(3):507-19. Epidemiol Infect. 2003. PMID: 12825737 Free PMC article.
-
Evaluation of urban measles mass campaigns for children aged 9-59 months in Mali.J Infect Dis. 2003 May 15;187 Suppl 1:S69-73. doi: 10.1086/368025. J Infect Dis. 2003. PMID: 12721894
-
Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia.Bull World Health Organ. 2001;79(7):588-95. Bull World Health Organ. 2001. PMID: 11477961 Free PMC article.
-
Population immunity to measles in the United States, 1999.J Infect Dis. 2004 May 1;189 Suppl 1:S91-7. doi: 10.1086/377713. J Infect Dis. 2004. PMID: 15106096 Review.
-
Implementation of a mass measles campaign in central Afghanistan, December 2001 to May 2002.J Infect Dis. 2003 May 15;187 Suppl 1:S186-90. doi: 10.1086/368335. J Infect Dis. 2003. PMID: 12721912 Review.
Cited by
-
Measles susceptibility in children in Karachi, Pakistan.Vaccine. 2011 Apr 18;29(18):3419-23. doi: 10.1016/j.vaccine.2011.02.087. Epub 2011 Mar 9. Vaccine. 2011. PMID: 21396902 Free PMC article.
-
SARS-CoV-2 Specific IgG Antibodies Persist Over a 12-Month Period in Oral Mucosal Fluid Collected From Previously Infected Individuals.Front Immunol. 2021 Dec 9;12:777858. doi: 10.3389/fimmu.2021.777858. eCollection 2021. Front Immunol. 2021. PMID: 34956206 Free PMC article.
-
Benefits and Challenges in Using Seroprevalence Data to Inform Models for Measles and Rubella Elimination.J Infect Dis. 2018 Jul 2;218(3):355-364. doi: 10.1093/infdis/jiy137. J Infect Dis. 2018. PMID: 29562334 Free PMC article.
-
Saliva-Based ELISAs for Effective SARS-CoV-2 Antibody Monitoring in Vaccinated Individuals.Front Immunol. 2021 Sep 3;12:701411. doi: 10.3389/fimmu.2021.701411. eCollection 2021. Front Immunol. 2021. PMID: 34539632 Free PMC article. Review.
-
Immunization Coverage Surveys and Linked Biomarker Serosurveys in Three Regions in Ethiopia.PLoS One. 2016 Mar 2;11(3):e0149970. doi: 10.1371/journal.pone.0149970. eCollection 2016. PLoS One. 2016. PMID: 26934372 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials